ALZN
Price
$2.32
Change
+$0.12 (+5.45%)
Updated
Aug 4, 01:34 PM (EDT)
Capitalization
6.42M
SNSE
Price
$9.87
Change
-$0.45 (-4.36%)
Updated
Aug 4, 10:53 AM (EDT)
Capitalization
13.01M
Interact to see
Advertisement

ALZN vs SNSE

Header iconALZN vs SNSE Comparison
Open Charts ALZN vs SNSEBanner chart's image
Alzamend Neuro
Price$2.32
Change+$0.12 (+5.45%)
Volume$200
Capitalization6.42M
Sensei Biotherapeutics
Price$9.87
Change-$0.45 (-4.36%)
Volume$600
Capitalization13.01M
ALZN vs SNSE Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. SNSE commentary
Aug 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Buy and SNSE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 04, 2025
Stock price -- (ALZN: $2.20 vs. SNSE: $10.32)
Brand notoriety: ALZN and SNSE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 5% vs. SNSE: 1372%
Market capitalization -- ALZN: $6.42M vs. SNSE: $13.01M
ALZN [@Biotechnology] is valued at $6.42M. SNSE’s [@Biotechnology] market capitalization is $13.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $213.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileSNSE’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • SNSE’s FA Score: 1 green, 4 red.
According to our system of comparison, SNSE is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 5 TA indicator(s) are bullish while SNSE’s TA Score has 5 bullish TA indicator(s).

  • ALZN’s TA Score: 5 bullish, 3 bearish.
  • SNSE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than SNSE.

Price Growth

ALZN (@Biotechnology) experienced а -25.68% price change this week, while SNSE (@Biotechnology) price change was +47.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.54%. For the same industry, the average monthly price growth was +13.95%, and the average quarterly price growth was +10.20%.

Reported Earning Dates

ALZN is expected to report earnings on Jul 22, 2025.

SNSE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-3.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNSE($13M) has a higher market cap than ALZN($6.42M). SNSE YTD gains are higher at: 5.336 vs. ALZN (-78.927). ALZN has higher annual earnings (EBITDA): -4.16M vs. SNSE (-27.93M). ALZN has less debt than SNSE: ALZN (301K) vs SNSE (3.21M). ALZN (0) and SNSE (0) have equivalent revenues.
ALZNSNSEALZN / SNSE
Capitalization6.42M13M49%
EBITDA-4.16M-27.93M15%
Gain YTD-78.9275.336-1,479%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.36MN/A-
Total Debt301K3.21M9%
TECHNICAL ANALYSIS
Technical Analysis
ALZNSNSE
RSI
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
67%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
78%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXGL2.570.32
+14.23%
NexGel
SGMO0.560.02
+4.56%
Sangamo Therapeutics
LVRO2.070.07
+3.25%
Lavoro Limited
AUB31.30-0.40
-1.26%
Atlantic Union Bankshares Corp
WBD12.87-0.30
-2.28%
Warner Bros Discovery

SNSE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+38.03%
VSTM - SNSE
47%
Loosely correlated
-1.46%
MOLN - SNSE
43%
Loosely correlated
-4.59%
ALZN - SNSE
40%
Loosely correlated
-2.22%
INAB - SNSE
38%
Loosely correlated
-0.94%
FATE - SNSE
36%
Loosely correlated
-2.73%
More